About Us

An accomplished medical device executive, Dr Misell has more than 20 years of clinical research experience spanning several therapeutic areas, including oncology, infertility, diabetes, metabolic disorders, neurology, exercise physiology, rheumatology, and dermatology. Dr Misell earned her doctoral degree in Metabolic Biochemistry from the University of California, Berkeley. In addition to fulfilling the role as a principal investigator during her time in academia, Dr Misell has directed studies across all phases of development from pilot to postapproval and registry studies.

Prior to joining GT Medical Technologies, Dr Misell was the vice president of Clinical and Medical Affairs at Dyve Biosciences. While there, she ran the clinical department, which executed more than 20 proof-of-concept trials and a phase 2 rheumatology trial with 20 clinical sites across the US. Prior to joining Dyve, she was the vice president of Clinical Affairs at Ulthera, Inc., where she built the Clinical Affairs department and ran more than 50 clinical studies. She has held similar roles at Suneva Medical, KineMed, and Allergan. At Allergan, she was responsible for managing more than 45 investigator-initiated studies, multisite comparator trials, and a registry study that enrolled more than 1000 subjects across more than 20 sites. For GT Medical Technologies, Dr Misell contributes expertise in developing clinical programs and registries for existing and pipeline products.